microdosing tirzepatide menopause Is Safe? vs. Standard Titration Microdosing GLP-1s: A Doctor's Guide

According to the company's FAQ, many people notice appetite changes early, with more visible weight loss typically building over the first 4 to 12 weeks and continuing over months with consistency

Medical supervision: not required

GLP-1 (glucagon-like peptide-1) is one such incretin hormone, but it does more than just influence satiety: It also plays an important role in the management of blood sugar levels and can improve blood sugar levels in people living with impaired glucose tolerance, prediabetes, or diabetes

How It Works : Tirzepatide also affects GLP-1, but it additionally influences another hormone called GIP